Cue Biopharma Inc (CUE)

1.705 +0.22 (+14.81%) USD  |  NASDAQ  |  Nov 05, 16:00
1.74 +0.04 (+2.05%) After-Hours: 18:33
More

Cue Biopharma EV to EBITDA

EV to EBITDA Chart

View EV to EBITDA for CUE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EV to EBITDA Data

View and export this data back to . Upgrade now.
Date Value

EV to EBITDA Definition

The EV to EBITDA measures the ratio between enterprise value and earnings before interest, taxes, depreciation, and amortization. This metric is important to analyze when looking at a company's true value based on how much they are valued at compared to how money they are earning.

Read full definition.

EV to EBITDA Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

EV to EBITDA Benchmarks

Biomarin Pharmaceutical Inc Upgrade
Arbutus Biopharma Corp --
GlycoMimetics Inc --
FibroGen Inc --
Cidara Therapeutics Inc --

EV to EBITDA Related Metrics

EV to CFO Upgrade
EV to Revenues Upgrade
EV to Free Cash Flow Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade